10
1. 9. 2023.
Treatment consistent with idiopathic multicentric Castleman disease guidelines is associated with improved outcomes
Key Points • Fifty-two percent of patients with iMCD treated with siltuximab with/without corticosteroids achieved response.• Corticosteroids alone are not effective in iMCD symptom management.